Inferior control arms in oncology trials in LMICs: contextualised or compromised? In recent years, cancer drug randomised controlled trials (RCTs) have been criticised for employing a control arm treatment that is inferior or suboptimal to the existing standard of care.1 2 Using an...

✅ Highlights the urgent need for equity & global trial harmonization.

❓ Question to think: Should trial standards always reflect the best global care — or adapt to local realities?

#OncoEthics #GlobalOncology #ClinicalTrials #OncoTwitter #Medicalwatch
bmjoncology.bmj.com/content/4/1/...